Restrictive cardiomyopathy is a condition where the walls of the heart’s lower chambers become stiff, preventing them from relaxing and filling with blood properly between beats. It is the rarest of the three main types of cardiomyopathy, accounting for roughly 5% of all diagnosed cases. Because the heart can’t fill adequately, it struggles to pump enough blood to meet the body’s needs, eventually leading to heart failure.
How the Heart Changes
In a healthy heart, the lower chambers (ventricles) stretch and relax after each contraction, allowing blood to flow in freely. In restrictive cardiomyopathy, the ventricular walls lose that flexibility. They may look normal in size and thickness, and the heart’s squeezing power often remains close to normal, at least early on. The problem is entirely about relaxation and filling.
Because less blood enters the ventricles with each heartbeat, the amount pumped out (stroke volume) drops. The heart compensates by beating faster, but that strategy has limits. Over time, blood backs up into the upper chambers (atria), which stretch and enlarge. Pressure also builds in the veins leading to the heart, causing fluid to accumulate in the lungs, abdomen, and legs.
What Causes It
Restrictive cardiomyopathy has a long list of potential causes, grouped into four broad categories.
- Infiltrative disorders: Abnormal proteins or inflammatory cells deposit in the heart muscle. Amyloidosis, where misfolded proteins accumulate in tissue, is the most common infiltrative cause. The protein deposits physically separate heart muscle cells, cause cellular damage, and stiffen the tissue. Sarcoidosis, an inflammatory condition that forms tiny clumps of immune cells, can also infiltrate the heart.
- Storage diseases: Conditions like hemochromatosis (iron overload) and Fabry disease cause specific substances to build up inside heart cells, gradually impairing their ability to relax.
- Endomyocardial disorders: The inner lining of the heart thickens or scars. Causes include radiation therapy to the chest, certain medications, carcinoid tumors, and a condition called endomyocardial fibrosis, which is more common in tropical regions.
- Idiopathic (no identifiable cause): In some cases, the heart stiffens without any detectable underlying disease. This form can run in families.
When there is a genetic basis, mutations in the TNNI3 gene are among the best-studied culprits. This gene provides instructions for making a protein involved in heart muscle relaxation. About 10 known mutations in TNNI3 alter the protein so it can no longer interact properly with other muscle components, directly disrupting the heart’s ability to relax between beats.
Symptoms and How It Feels
People with restrictive cardiomyopathy often don’t notice anything until the disease is fairly advanced. The symptoms develop gradually and closely mirror those of heart failure.
Shortness of breath is usually the first complaint, initially with exertion and later at rest. Many people report waking at night feeling unable to catch their breath, or needing extra pillows to sleep comfortably. Fatigue and declining exercise tolerance creep in as the heart’s output falls. Fainting, particularly during physical activity, can occur and is considered a serious warning sign because it reflects the heart’s inability to increase its output when the body demands more blood.
As blood backs up on the right side of the heart, fluid accumulates in the lower body. Swelling in the ankles and legs, an enlarged liver, pain in the upper right abdomen, and a swollen belly from fluid buildup (ascites) are all common. Some people notice that their neck veins become visibly distended, especially when taking a deep breath, a phenomenon that reflects abnormal pressure dynamics inside the stiffened heart.
How It’s Diagnosed
Diagnosing restrictive cardiomyopathy can be tricky because its symptoms overlap with many other heart conditions. Echocardiography (heart ultrasound) is typically the first imaging test. It reveals a characteristic pattern: both atria are enlarged, the ventricles are normal in size, and the heart’s squeezing function looks preserved. Specialized ultrasound techniques can measure how quickly blood flows into the ventricles and how well the heart muscle itself relaxes, both of which are abnormal in this condition.
One of the biggest diagnostic challenges is distinguishing restrictive cardiomyopathy from constrictive pericarditis, a condition where the sac surrounding the heart thickens and restricts filling. The distinction matters enormously because constrictive pericarditis can often be cured with surgery, while restrictive cardiomyopathy cannot. Doctors use a combination of tools to tell them apart: tissue Doppler imaging on echocardiography, cardiac MRI to look at the heart muscle and pericardium in detail, CT scanning to detect pericardial thickening or calcification, and sometimes cardiac catheterization to directly measure pressures inside the heart chambers. In difficult cases, a small tissue sample (biopsy) from the heart can provide a definitive answer and may also reveal the underlying cause, such as amyloid deposits or iron overload.
Blood tests for specific markers, along with cardiac MRI, help identify the underlying cause. MRI is particularly useful for spotting amyloidosis, sarcoidosis, and iron overload based on distinctive patterns in the heart tissue.
Treatment and Daily Management
There is no treatment that reverses the stiffness of the heart muscle itself. The strategy focuses on two goals: managing heart failure symptoms and treating the underlying cause when one can be identified.
Diuretics (water pills) are the cornerstone of symptom relief, helping the body shed excess fluid and reducing swelling, breathlessness, and abdominal discomfort. Dosing requires careful balance because removing too much fluid can drop blood pressure dangerously in a heart that already pumps a fixed, small volume of blood per beat. For the same reason, some common heart medications can actually make things worse. Beta-blockers and certain blood pressure medications may lower heart rate or blood pressure to harmful levels, since the stiff heart relies on a faster heart rate to maintain adequate output.
When a treatable cause is found, addressing it can slow or sometimes halt disease progression. Iron-removal therapy helps in hemochromatosis. Newer targeted therapies have improved outcomes in certain types of amyloidosis. Sarcoidosis may respond to medications that suppress the immune system’s inflammatory response.
Dietary changes play a supporting role. Most heart failure guidelines recommend keeping sodium intake between 1,500 and 3,000 milligrams per day, with stricter limits for people with more severe symptoms. Some treatment plans also include fluid restriction, commonly to about 1.5 liters per day, to prevent fluid from building up faster than the body can handle it.
For people whose condition continues to worsen despite medical therapy, heart transplantation may be the only remaining option. This is particularly relevant in children. Data from a pediatric cardiomyopathy registry found that while overall five-year survival was about 71%, transplant-free survival at five years dropped to just 22% in children with the pure restrictive form, meaning most required a transplant to survive.
Long-Term Outlook
Prognosis depends heavily on what’s causing the stiffness and how advanced it is at diagnosis. Idiopathic cases and cardiac amyloidosis tend to carry the most serious outlook, while conditions like hemochromatosis may stabilize with treatment. Abnormal heart rhythms, blood clots forming in the enlarged atria, and progressive heart failure are the main complications that drive outcomes.
Regular monitoring with echocardiography and blood tests helps track how well the heart is functioning over time. Because restrictive cardiomyopathy can progress silently before symptoms worsen noticeably, staying on top of scheduled follow-up is important even during periods when you feel stable. For families with a genetic form of the disease, screening of close relatives can catch the condition before symptoms develop.